166 related articles for article (PubMed ID: 1483936)
1. Flow cytometric analyses of the characteristics of tumor cells treated with two platinum compounds: 1,1-cyclobutanedicarboxylato(2-aminomethylpyrrolidine)- platinum(II) and cisplatin.
Inoue S; Mizuno S; Ito M; Ohnuma T
Jpn J Cancer Res; 1992 Nov; 83(11):1231-40. PubMed ID: 1483936
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activities of new platinum compounds, DWA2114R, NK121 and 254-S, against human leukemia cells sensitive or resistant to cisplatin.
Kobayashi H; Takemura Y; Miyachi H; Ogawa T
Invest New Drugs; 1991 Nov; 9(4):313-9. PubMed ID: 1804804
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo antineoplastic activity of a new platinum antineoplastic agent, (R)-(-)-1,1-cyclobutanedicarboxylate (2-aminomethylpyrrolidine)-platinum (II) (DWA2114R) on freshly separated human tumor cells and human tumor xenografts transplanted in nude mice--a comparison with cis-diammine-dichloroplatinum (CDDP).
Nio Y; Imai S; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Tobe T
Anticancer Res; 1991; 11(2):761-7. PubMed ID: 2064331
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice.
Endo K; Akamatsu K; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
Anticancer Res; 1992; 12(1):49-58. PubMed ID: 1567181
[TBL] [Abstract][Full Text] [Related]
5. In vitro antitumor mechanism of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++) platinum(II).
Akamatsu K; Endo K; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
Anticancer Res; 1991; 11(1):151-5. PubMed ID: 2018348
[TBL] [Abstract][Full Text] [Related]
6. In vitro antitumor activity of a new platinum complex, DWA2114R against human tumor cell lines.
Akamatsu K; Saito H; Tsunenari T; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
Anticancer Res; 1993; 13(6A):2261-5. PubMed ID: 8297143
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity and cellular accumulation of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)platinum( II) monohydrate, in cisplatin-sensitive and -resistant murine P388 leukemia cells.
Kamisango K; Matsumoto T; Akamatsu K; Morikawa K; Tashiro T; Koizumi K
Jpn J Cancer Res; 1992 Mar; 83(3):304-11. PubMed ID: 1582895
[TBL] [Abstract][Full Text] [Related]
8. Potent antitumour activity of (-)-(R)-2-aminomethylpyrrolidine (1,1-cyclobutanedicarboxylato)platinum(II) monohydrate (DWA2114R) against advanced L1210 leukaemia in mice.
Akamatsu K; Endo K; Matsumoto T; Kamisango K; Morikawa K; Koizumi M; Koizumi K
Br J Cancer; 1992 Nov; 66(5):827-32. PubMed ID: 1419625
[TBL] [Abstract][Full Text] [Related]
9. A new anticancer platinum compound, (-)-(R)-2-aminomethyl-pyrrolidine(1,1-cyclobutanedicarboxylato) platinum(II): DNA interstrand crosslinking, repair and lethal effects in normal human, Fanconi's anaemia and xeroderma pigmentosum cells.
Fujiwara Y; Nakamura M; Yokoo S
Br J Cancer; 1993 Jun; 67(6):1285-92. PubMed ID: 8512813
[TBL] [Abstract][Full Text] [Related]
10. [Flow cytometric analysis of the effect of DWA2114R on the cell cycle traverse of RPMI 8402 cells--comparison with CDDP].
Takamoto S; Souma R
Gan To Kagaku Ryoho; 1992 Apr; 19(4):469-76. PubMed ID: 1558396
[TBL] [Abstract][Full Text] [Related]
11. The interactions of (-)-(R)-2-aminomethylpyrrolidine (1,1-cyclobutanedicarboxylato)platinum(II) monohydrate (DWA2114R) and related compounds with deoxyribonucleic acid.
Morikawa K; Matsumoto T; Matsuoka Y; Koizumi K
Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):212-9. PubMed ID: 1576676
[TBL] [Abstract][Full Text] [Related]
12. Mechanism-related circumvention of Cisplatin resistance in human ovarian-carcinoma cells by (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanediacarboxylato)-platinum (ii) monohydrate and modulation of its sensitivity by 12-o-tetradecanoylphorbol-13-acetate.
Isonishi S; Ochiai K; Yasuda M; Ohkawa K; Terashima Y
Int J Oncol; 1994 Dec; 5(6):1309-14. PubMed ID: 21559715
[TBL] [Abstract][Full Text] [Related]
13. [Effect of treatment schedule of an antitumor platinum complex, DWA2114R, on the antitumor activity].
Endo K; Akamatsu K; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
Gan To Kagaku Ryoho; 1992 Feb; 19(2):223-8. PubMed ID: 1736834
[TBL] [Abstract][Full Text] [Related]
14. Binding characteristics of (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-2-platin um(II) to DNA, RNA and protein molecules in HeLa cells and its lethal effect: comparison with cis- and trans-diamminedichloroplatinums(II).
Akaboshi M; Kawai K; Ujeno Y; Takada S; Miyahara T
Jpn J Cancer Res; 1994 Jan; 85(1):106-11. PubMed ID: 7508903
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric analysis of the kinetic effects of cisplatin on lung cancer cells.
Fujikane T; Shimizu T; Tsuji T; Ishida S; Ohsaki Y; Onodera S
Cytometry; 1989 Nov; 10(6):788-95. PubMed ID: 2582970
[TBL] [Abstract][Full Text] [Related]
16. BrdUrd/DNA flow cytometry analysis demonstrates cis-diamminedichloroplatinum (II)-induced multiple cell-cycle modifications on human lung carcinoma cells.
Demarcq C; Bastian G; Remvikos Y
Cytometry; 1992; 13(4):416-22. PubMed ID: 1526199
[TBL] [Abstract][Full Text] [Related]
17. Toxicological and tumoricidal evaluations of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++)platinum( II) monohydrate, in rats.
Akamatsu K; Endo K; Matsumoto T; Morikawa K; Koizumi M; Koizumi K; Mitsui H
Jpn J Cancer Res; 1991 Jun; 82(6):724-31. PubMed ID: 1906857
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the antitumour effects and nephrotoxicity-inducing activities of two new platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++)-platinum (II) monohydrate, and its enantiomeric isomer.
Matsumoto T; Endoh K; Akamatsu K; Kamisango K; Mitsui H; Koizumi K; Morikawa K; Koizumi M; Matsuno T
Br J Cancer; 1991 Jul; 64(1):41-6. PubMed ID: 1854626
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of platinum analogs against human lung cancer cell lines and tumor specimens.
Yonei T; Ohnoshi T; Hiraki S; Ueoka H; Kiura K; Moritaka T; Shibayama T; Tabata M; Segawa Y; Takigawa N
Acta Med Okayama; 1993 Aug; 47(4):233-41. PubMed ID: 8213217
[TBL] [Abstract][Full Text] [Related]
20. Establishment and characterization of acquired resistance to platinum anticancer drugs in human ovarian carcinoma cells.
Misawa T; Kikkawa F; Maeda O; Obata NH; Higashide K; Suganuma N; Tomoda Y
Jpn J Cancer Res; 1995 Jan; 86(1):88-94. PubMed ID: 7737915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
